Codes / ICD10CM / Q80.3

Q80.3 Congenital bullous ichthyosiform erythroderma

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Congenital bullous ichthyosiform erythroderma

Summary

Congenital bullous ichthyosiform erythroderma is a rare genetic skin disorder characterized by widespread erythema (redness), blistering, and scaling at birth or shortly after. It results from defects in skin barrier function, leading to abnormal keratinization and increased susceptibility to skin breakdown. Severity varies, with some cases involving systemic involvement or secondary complications.

Causes

Congenital bullous ichthyosiform erythroderma is primarily caused by genetic mutations affecting skin structure and function. Most cases are inherited in an autosomal recessive pattern, though sporadic mutations occur. Specific genes involved regulate keratinocyte differentiation or lipid metabolism, disrupting the skin’s protective barrier.

Risk Factors

  • Family history of ichthyosis or related skin disorders.
  • Consanguineous parental relationships (increased recessive risk).
  • Certain ethnic backgrounds with higher prevalence of specific subtypes.

Symptoms

  • Generalized erythema and blistering at birth or shortly after.
  • Dry, scaly skin with varying thickness and texture.
  • Skin cracking, fissuring, or peeling.
  • Potential for secondary infections due to skin barrier disruption.
  • Variable involvement of palms, soles, or mucous membranes depending on subtype.

Diagnosis

Diagnosis is based on clinical presentation, family history, and skin biopsy. Genetic testing may confirm specific mutations. Clinical evaluation focuses on distinguishing the condition from other ichthyosis subtypes or blistering disorders.

Treatment Options

Management includes topical therapies (emollients, keratolytics) to reduce scaling and blistering, systemic retinoids (in severe cases), and infection prevention. Supportive care, such as wound care and hydration, is often necessary. Treatment plans are individualized based on severity.

Prognosis and Follow-Up

Prognosis varies with severity; milder cases may improve with age, while severe forms may require lifelong management. Regular follow-up with dermatology is recommended to monitor skin health, address complications, and adjust treatment as needed.

Complications

  • Secondary bacterial or fungal infections due to skin barrier disruption.
  • Dehydration or electrolyte imbalances from fluid loss.
  • Eye or mucous membrane involvement in severe cases.
  • Psychological impact from chronic skin symptoms.

Lifestyle & Prevention

  • Use gentle, fragrance-free skincare products to avoid irritation.
  • Maintain skin hydration with regular moisturizing.
  • Protect skin from trauma or friction to reduce blistering.
  • Avoid extreme temperatures or low humidity, which may exacerbate symptoms.

When to Seek Professional Help

Seek care if symptoms worsen, new blisters or infections develop, or there are signs of dehydration (e.g., reduced urination, lethargy). Prompt evaluation is important for managing complications or adjusting treatment.

Tips for Medical Coders

Document clinical details supporting the diagnosis, including onset (congenital), skin findings (erythema, blistering, scaling), and family history if available. Ensure coding aligns with the specific subtype and any associated complications. Use additional codes for related conditions (e.g., infections) as appropriate.

Book a walkthrough

Q80.3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.